ライフサイエンスコーパス: HBP

1 HBP and hypercholesterolemia were the most prevalent com

2 HBP and pre-HBP in children and adolescents are on the r

3 HBP ascertainment was based on age-, gender-, and height

4 HBP can also overcome bundle branch block patterns, and

5 HBP genes were overexpressed in human prostate cancers a

6 HBP is a strong chemoattractant for monocytes that also

7 HBP levels are dramatically increased in patients with A

8 HBP regulation by GFPT is well studied but other HBP reg

9 HBP threshold at implant was 1.5 (2.3) V at 1.5 (1.0) ms

10 HBP was administered to mice at different concentrations

11 HBP was associated with a greater short-term improvement

12 HBP was followed by LV pacing at a delay equal to His-ve

13 blished that HMG-box transcription factor 1 (HBP-1), a Wnt/B-catenin signaling inhibitor, is a target

14 blished that HMG-box transcription factor 1 (HBP-1), a Wnt/beta-catenin signaling inhibitor, is a tar

15 In addition, HBP had an additive effect on LPS-induced production of

16 D32w expression in PECs did not change after HBP or CLP.

17 hemical mutagenesis to determine alternative HBP regulation.

18 Correlations among HBP concentrations, disease severity and fluid balance w

19 BP and HBP reversed their downward trends 10 years after the in

20 Pre-HBP and HBP increased 2.3% (P=0.0003) and 1% (P=0.17), respectiv

21 The BP, pre-HBP, and HBP trends were downward from 1963 to 1988 and upward th

22 ent call for early prevention of obesity and HBP and illustrate racial/ethnic disparities in this age

23 As HBP levels increase prior to other known biomarkers, HBP

24 to (i) validate a LC-MS method that assesses HBP flux as UDP-GlcNAc ((13)C)-molar percent enrichment

25 determinant for washout of gadoxetic acid at HBP (P < .001).

26 , which included the retention or washout at HBP and degree of transporter expression.

27 opolysaccharide (LPS) resulted in attenuated HBP activity and protein O-GlcNAcylation.

28 the curve (AUC: 0.82), followed by baseline HBP (0.79), PCT (0.72), lactate (0.71), and CRP (0.65),

29 eatitis, but we found no correlation between HBP concentration and fluid balance.

30 There was no correlation between HBP threshold and lead location on the His cloud.

31 ls increase prior to other known biomarkers, HBP has emerged as a promising early predictor of severe

32 e LKB1-AMPK and the hexosamine biosynthesis (HBP)-OGT pathways, which coordinate together for the sen

33 6,6',13,13'-Tetrahydro-6,6'-bipentacene (HBP), the intermediate molecule connecting pentacene to

34 The crystal structure of a histamine-bound HBP, determined at 1.25 A resolution, reveals a lipocali

35 ure (OBP), ambulatory BP (ABP), and home BP (HBP) can inform which is best for diagnosing hypertensio

36 fferent interventions and inform the broader HBP deliberative process however have limitations.

37 The QRS narrowing by HBP may not always be optimal.

38 lts suggest that altered nutrient sensing by HBP with age may be the link among nutrients, insulin re

39 pothesized that altered nutrient sensing (by HBP) with age may provide a link among aging, nutrient f

40 f perfusions had no effect on the calculated HBP flux at ~2.3 and 2.5 nmol/g of heart protein/min, re

41 [U-(13)C(6)]glucose; however, the calculated HBP flux was similar among the glucose concentrations at

42 Azurocidin/CAP37/HBP is an antimicrobial and chemotactic protein that is

43 se availability or workload regulate cardiac HBP flux.

44 that with glucosamine alone without changing HBP product levels.

45 ing of fluorescein isothiocyanate-conjugated HBP to human monocytes in the presence of EDTA and the p

46 visits) or 24-h ABP, systolic and diastolic HBP (1 week) were more reliable and more strongly associ

47 ABP, 10 mm Hg higher systolic and diastolic HBP were associated with 5.07 (standard error [SE]: 1.48

48 imulating the His-Purkinje network directly, HBP results in synchronized ventricular activation, whic

49 QRS duration at baseline, during HBP, biventricular pacing, and HOT-CRT was measured.

50 lar pacing ( P=0.003), to 151+/-24 ms during HBP ( P<0.0001), and further to 120+/-16 ms during HOT-C

51 Enhanced HBP activity contributed to aortic dilatation and medial

52 Finally, HBPs had higher lipid unsaturation levels than HWPs for

53 ) significantly reduced the affinity of FITC-HBP for CD14-positive monocytes.

54 appeared in 1988 for pre-HBP and in 1999 for HBP; non-Hispanic blacks and Mexican Americans had a gre

55 s In a multivariable Cox model adjusting for HBP as a time-varying covariate, comparing those on PCB

56 After adjustment for HBP, neither systolic or diastolic OBP nor ABP was assoc

57 Indications for HBP were sinus node dysfunction, atrioventricular conduc

58 he data we obtained in the present study for HBP enables a comparison of the driving forces for bindi

59 bjective was to describe a new technique for HBP directly guided by electroanatomic mapping (EAM).

60 between the low affinity binding site of FS-HBP and monomine, suggesting that histamine binding has

61 imilar to the lower, low affinity site of FS-HBP.

62 emale-specific histamine-binding protein (FS-HBP), the histamine-binding lipocalin of the tick Rhipic

63 48-h HBP change (HBPc-48 h) had greater predictive accuracy o

64 0.66; 95% CI 0.48-0.91) less likely to have HBP.

65 that in the healthy ex vivo perfused heart, HBP flux does not respond to acute changes in glucose av

66 As soluble receptors of histamine, HBPs offer a new strategy for controlling histamine-base

67 ic-hydrophobic heterostructure particles (HL-HBPs), synthesized by a surface heterogeneous nanostruct

68 However, HBP is not a biologically inactive molecule but rather a

69 man monocytes activated by recombinant human HBP and LPS and their interaction with the LPS receptor

70 ability to convert DBT to 2-hydroxybiphenyl (HBP) with the release of inorganic sulfur.

71 Our findings identify HBP as a modulator of prostate cancer growth and c-MYC a

72 and we hypothesized that dynamic changes in HBP may reflect the severity of sepsis.

73 was accompanied by absolutely no increase in HBP product levels in all of the muscles examined.

74 nding of structure-function relationships in HBP.

75 ition, explaining how AMDHD2 LOF resulted in HBP activation.

76 ral obesity, partially explained the rise in HBP and pre-HBP from 1988 to 1999.

77 nce is additive to that induced by increased HBP flux via glucosamine infusion and, if so, whether su

78 Here, we observed increased HBP flux and hyper-O-GlcNAcylation in human pancreatic d

79 pheral insulin resistance without increasing HBP product levels in skeletal muscle.

80 ged 2 leptospiral proteins as able to induce HBP degranulation.

81 microscopy showed that monocytes internalize HBP within 30 min.

82 nstrated that administration of 10 microg ip HBP alone did not enhance phagocytosis of fluorescent Es

83 dministration of 10 microg and 100 microg ip HBP demonstrated a 1.7-fold increase in the total number

84 ice that received cefoxitin and 50 microg ip HBP immediately after CLP, followed by continuous admini

85 4 was clearly differentiated from the 95 kDa HBP by two-dimensional electrophoretic mobility.

86 We conclude that the 95 kDa HBP is a new HDL receptor candidate widely expressed in

87 not affect either HDL binding to the 95 kDa HBP or its size, while in contrast it affected the molec

88 The association of HDL(3) with the 95 kDa HBP plateaued in 15-30 min while dissociation was comple

89 The HDL binding with the 95 kDa HBP plateaus at 2.5-5 microg/mL under reducing and nonre

90 The 95 kDa HBP predominantly resides on the surface of cells since

91 I, and apoA-II were recognized by the 95 kDa HBP while low density lipoproteins (LDL) and tetranitrom

92 r 100 mum), which bypasses the rate-limiting HBP enzyme.

93 able as an online tool that can inform local HBP deliberation and support efficient investment in UHC

94 An inability to directly measure HBP flux has hindered our understanding of the factors r

95 ector interventions recommended in the model HBP termed essential universal health coverage (EUHC).

96 d with four- to fivefold increases in muscle HBP product levels.

97 ipid infusion also failed to increase muscle HBP product levels.

98 such additive effects correlate with muscle HBP product levels.

99 r accurate differentiation between S-HBP, NS-HBP, and right ventricular septal capture morphologies b

100 p accurately differentiate between S-HBP, NS-HBP, and right ventricular septal pacing with a cumulati

101 OBP, HBP, and ABP assess somewhat distinct parameters.

102 The correlations among OBP, HBP, and ABP, corrected for regression dilution bias, we

103 tudy aimed to assess the reliability of OBP, HBP, and ABP and evaluate their associations with left v

104 The activation of HBP induces an aberrant cell surface glycosylation and O

105 ats, we show that experimental activation of HBP, through the systemic infusion of glucosamine, induc

106 The addition of HBP imaging did not affect interreader agreement but sig

107 Intravenous administration of HBP (0.1, 1, and 10 microg) at the time of CLP showed an

108 LP, followed by continuous administration of HBP (12 microg/24 hrs).

109 erformance liquid chromatography analyses of HBP metabolic activity, short term exposure to an exogen

110 and data are accumulating on the benefit of HBP for cardiac resynchronization therapy.

111 onocytes was mediated by specific binding of HBP to monocytes, which resulted in an up-regulation of

112 for 200 h results in pale golden crystals of HBP and amorphous material containing pentacene oligomer

113 microM) significantly reduced the effect of HBP (10 microg/ml) to enhance LPS (10 ng/ml)-induced TNF

114 an and EDTA abrogate the enhancing effect of HBP on LPS-induced TNF-alpha production.

115 hypothesized that the stimulatory effect of HBP on the LPS-induced release of proinflammatory mediat

116 nduced by CLP is important for the effect of HBP to enhance phagocytosis.

117 otransferase 1), the rate-limiting enzyme of HBP, promotes cardiomyocyte growth.

118 Expression of HBP enzyme glucosamine-phosphate N-acetyltransferase 1 (

119 Direct guidance of HBP by EAM allows for direct visualization of the pacing

120 Continued heating of HBP results in co-crystals of 6,13-dihydrogenated pentac

121 findings demonstrate that internalization of HBP in monocytes is essential for the enhancement of LPS

122 ave clinical implications, as high levels of HBP were detected in serum from patients with leptospiro

123 anterior) were taken for the measurement of HBP product levels.

124 Pretreatment with 10 microg of HBP did not further enhance CD11b/CD18 expression in PEC

125 owever, 24-hr pretreatment with 10 microg of HBP followed by CLP increased phagocytosis in PECs 1.8-f

126 s before CLP with 10 microg or 100 microg of HBP without cefoxitin (p = .01, Cox-Mantel log-rank test

127 eased total O-GlcNAc without modification of HBP enzyme expression.Treatment improved circulating par

128 ON Data from ECOG 4599 suggest that onset of HBP during treatment with PCB may be associated with imp

129 exican Americans had a greater prevalence of HBP and pre-HBP than non-Hispanic whites, and males had

130 e foundational analyses of the regulation of HBP flux and protein O-GlcNAcylation.

131 heir secreted products induce the release of HBP from stimulated neutrophils through a controlled deg

132 To assess the role of HBP in the induction of TRIB3, we demonstrated that the

133 BP are needed to further explore the role of HBP in the pathogenesis of AP and its possible clinical

134 In this study, we investigated the role of HBP on HG-stimulated fibronectin protein synthesis, a ma

135 Transport of HBP to an activating compartment depends on intact F-act

136 recordings as a tool to identify the type of HBP morphology.

137 These data suggest that 1 week of HBP monitoring may be the best approach for diagnosing h

138 The reliability of 1 week of HBP, 3 office visits with mercury sphygmomanometry, and

139 sessed at 3 visits, and completed 3 weeks of HBP, 2 24-h ABP recordings, and a 2-dimensional echocard

140 paper, we have discussed the application of HBPs as viral uptake inhibitors in COVID-19 and explaine

141 Here, we review and discuss the use of HBPs as viral uptake inhibitors and will address their b

142 Additional studies on HBP are needed to further explore the role of HBP in the

143 regulation by GFPT is well studied but other HBP regulators have remained obscure.

144 His bundle pacing (HBP) may also improve clinical outcomes by narrowing QRS

145 His bundle pacing (HBP) remains technically challenging and is currently gu

146 His bundle pacing (HBP) results in physiological ventricular activation and

147 ve (S), nonselective (NS) His bundle pacing (HBP), and right ventricular septal capture in routine cl

148 ublished two model health benefits packages (HBPs).

149 ough the lens of "health benefits packages" (HBPs), which seek to establish which services the public

150 tterning of hepatic, biliary and pancreatic (HBP) structures from a 3D culture of human pluripotent s

151 The hexosamine biosynthesis pathway (HBP) branches from glycolysis and forms UDP-GlcNAc, the

152 role of the hexosamine biosynthesis pathway (HBP) in fat-induced insulin resistance, we examined whet

153 ated by the hexosamine biosynthesis pathway (HBP) in response to metabolic nutrients.

154 through the hexosamine biosynthesis pathway (HBP) induces insulin resistance and facilitates lipid st

155 whether the hexosamine biosynthesis pathway (HBP) mediates glucose regulation of mRNA expression, we

156 The hexosamine biosynthesis pathway (HBP) regulates the post-translational modification of nu

157 The hexosamine biosynthesis pathway (HBP) serves as a nutrient sensor and has been implicated

158 athway, the hexosamine biosynthesis pathway (HBP) via regulation of expression of glutamine:fructose-

159 Hexosamine biosynthesis pathway (HBP), a shunt pathway of glycolysis, is a metabolic node

160 sis through Hexosamine Biosynthesis Pathway (HBP), as well as cellular redox homeostasis, resulting i

161 ated by the hexosamine biosynthesis pathway (HBP), in which fructose-6-phosphate is converted to gluc

162 tion to the hexosamine biosynthesis pathway (HBP), or gain-of-function mig-22(k185gf) rescued ngat-1(

163 athway, the hexosamine biosynthesis pathway (HBP), rapidly decreased the expression of a cluster of n

164 lism is the hexosamine biosynthesis pathway (HBP).

165 through the hexosamine biosynthesis pathway (HBP).

166 duct of the hexosamine biosynthesis pathway (HBP).

167 ed with the hexosamine biosynthesis pathway (HBP).

168 ized by the hexosamine biosynthetic pathway (HBP) allows nuclear localization of YAP1.

169 irements of hexosamine biosynthetic pathway (HBP) and O-GlcNAc transferase (OGT) for Drosophila homeo

170 ctivate the hexosamine biosynthetic pathway (HBP) and promote the O-glycosylation of proteins by O-gl

171 The hexosamine biosynthetic pathway (HBP) generates uridine diphosphate N-acetylglucosamine (

172 through the Hexosamine Biosynthetic Pathway (HBP) has been tightly linked to PC development.

173 Hexosamine biosynthetic pathway (HBP) is a candidate nutrient-sensing pathway.

174 The hexosamine biosynthetic pathway (HBP) is highly dependent on multiple metabolic nutrients

175 through the hexosamine biosynthetic pathway (HBP) is implicated in the development of insulin resista

176 toward the hexosamine biosynthetic pathway (HBP) is required not only for osteoclast differentiation

177 ent-sensing hexosamine biosynthetic pathway (HBP) known to mediate glucose toxicity in diabetes.

178 The hexosamine biosynthetic pathway (HBP) plays critical roles in nutrient sensing, stress re

179 The hexosamine biosynthetic pathway (HBP) senses metabolic status and produces an essential s

180 ions in the hexosamine biosynthetic pathway (HBP) to be critical for CRPC.

181 s drive the hexosamine biosynthetic pathway (HBP) ultimately leading to the O-GlcNAc modification of

182 ment of the hexosamine biosynthetic pathway (HBP), increased O-GlcNAcylation, and p53 stabilization.

183 olysis, the hexosamine biosynthetic pathway (HBP), to increase uridine diphosphate-N-acetylglucosamin

184 enters the hexosamine biosynthetic pathway (HBP), which regulates levels of O-linked beta-N-acetylgl

185 h enter the hexosamine biosynthetic pathway (HBP).

186 Comparing the PCB HBP group with PC gave an adjusted PFS HR of 0.54 (95% C

187 Heparin-binding peptides (HBPs) are suitable nonanticoagulant agents that are capa

188 erventions such as heparin-binding peptides (HBPs), which are used for other cases, can be beneficial

189 Methods We attempted permanent HBP in 27 patients (left bundle branch block 17, intrave

190 a before widespread application of permanent HBP.

191 lable outcome data associated with permanent HBP.

192 without and set 2 with hepatobiliary phase [HBP] images).

193 gains achievable under a number of plausible HBP strategies for the country.

194 Hyperbranched polymers (HBPs) with decorated donor and acceptor chromophores in

195 Pre-HBP and HBP increased 2.3% (P=0.0003) and 1% (P=0.17), r

196 partially explained the rise in HBP and pre-HBP from 1988 to 1999.

197 HBP and pre-HBP in children and adolescents are on the rise.

198 cans had a greater prevalence of HBP and pre-HBP than non-Hispanic whites, and males had a greater pr

199 The BP, pre-HBP, and HBP trends were downward from 1963 to 1988 and

200 hnic and gender gap appeared in 1988 for pre-HBP and in 1999 for HBP; non-Hispanic blacks and Mexican

201 vigation of the pacing lead to predetermined HBP locations guided by EAM was achieved in all patients

202 High blood pressure (HBP) by the end of cycle 1 was defined as blood pressure

203 g) for the diagnosis of high blood pressure (HBP) in adolescents.

204 ty, we sought to assess high blood pressure (HBP) secular trends in children and adolescents enrolled

205 t morbidities of either high blood pressure (HBP), diabetes mellitus, osteoporosis, non-AIDS cancer,

206 of the European Union's Human Brain Project (HBP) and other large-scale brain research projects is th

207 Before this proposal, HBP had been defined as BP at or above the 95th percenti

208 We also propose HBP as a new early screening biomarker for human leptosp

209 he binding of the neutrophil-derived protein HBP to monocytes is inhibited in the presence of EDTA an

210 h density lipoprotein (HDL)-binding protein (HBP) corresponding to a high affinity HDL-binding site w

211 Heparin-binding protein (HBP) has been shown to be a robust predictor of the prog

212 The neutrophil heparin-binding protein (HBP) is an inflammatory mediator and potent inducer of v

213 e lipoprotein-anchored heme binding protein (HBP) of this transporter is SiaA (HtsA).

214 neutrophil-derived heparin-binding protein (HBP), also known as CAP37 or azurocidin, potentiates the

215 Heparin-binding protein (HBP), also known as CAP37, is a proteolytically inactive

216 leukocytes release heparin-binding protein (HBP; also known as CAP37 or azurocidin) from azurophilic

217 High-affinity histamine-binding proteins (HBPs) were discovered in the saliva of Rhipicephalus app

218 s by serum-derived heparin-binding proteins (HBPs).

219 Recombinant HBP increases survival in murine fecal peritonitis.

220 puncture (CLP) and treated with recombinant HBP and 60 mg/kg cefoxitin twice a day.

221 S-HBP was noted in 54 (36%) patients.

222 teria for accurate differentiation between S-HBP, NS-HBP, and right ventricular septal capture morpho

223 can help accurately differentiate between S-HBP, NS-HBP, and right ventricular septal pacing with a

224 spectively) and specific (90% and 94%) for S-HBP irrespective of baseline QRSd.

225 A novel device-based algorithm for S-HBP was proposed.

226 ate a greater activation of nutrient-sensing HBP with age in both old ad libitum-fed and calorie-rest

227 mine if CRT could be optimized by sequential HBP followed by left ventricular (LV) pacing (His-Optimi

228 EAM can be applied during standard HBP procedures or combined with atrioventricular nodal a

229 oscopy and electron microscopy, and suggests HBP as an intermediate to hydrogenated pentacene species

230 monstrate the therapeutic value of targeting HBP in CRPC.

231 We used flow cytometry to demonstrate that HBP had a high affinity to monocytes but not to the LPS

232 Our results demonstrated that HBP alone (10 microg/ml) stimulated the production of TN

233 We have previously demonstrated that HBP is internalized in monocytes.

234 These data provide supporting evidence that HBP binds to a receptor expressed on monocytes.

235 In the current study, we hypothesize that HBP is internalized in monocytes via endocytosis, and th

236 The HBP end product UDP-N-acetylglucosamine (UDP-GlcNAc) is

237 The HBP is a branch of the glucose metabolic pathway that co

238 The HBP may be involved in retinal neurodegeneration in diab

239 ata provide the mechanistic link between the HBP flux and insulin resistance and point to TRIB3 as a

240 Conversely, blocking the HBP with a GFA inhibitor reduced AMPK activity, ACC phos

241 nthesis in the mesangium are mediated by the HBP possibly via hexosamine regulation of CREB and PKC/P

242 demonstrating that AMPK is regulated by the HBP, we found that AMPK was recognized by succinylated w

243 into adipocytes where it directly enters the HBP.

244 In conclusion this study identifies the HBP as a metabolic pathway involved in GEM resistance an

245 T), which is the rate-limiting enzyme in the HBP pathway.

246 retention and washout, respectively, in the HBP.

247 Inhibiting the HBP through genetic and chemical methods reverses p53 st

248 N concentrations, unrestricted flux into the HBP greatly exceeds the biosynthetic capacity of the pat

249 hical, social, and philosophical issues, the HBP has made the identification, examination, and manage

250 eful in exploring the functional role of the HBP and in avoiding the potential pitfalls in the pharma

251 Thus, the activation of the HBP by nutrients represents a biochemical link between n

252 mechanism and functional significance of the HBP in directly linking extracellular glucose signal to

253 of the discrepant reports on the role of the HBP in glycogen metabolism.

254 Despite the established role of the HBP in metabolism and multiple diseases, regulation of t

255 genesis, demonstrating the importance of the HBP in the development of glucose intolerance.

256 s performed with direct visualization of the HBP lead by EAM.

257 Strikingly, addition of the HBP metabolite UDP-N-acetylglucosamine (UDP-GlcNAc) to C

258 ism and multiple diseases, regulation of the HBP remains largely undefined.

259 We now identify a regulatory arm of the HBP that involves rapid allosteric activation of glycoge

260 hanistically, persistent upregulation of the HBP triggers decompensated hypertrophy through activatio

261 ults reveal that chronic upregulation of the HBP under hemodynamic stress induces pathological cardia

262 rm exposure to an exogenous substrate of the HBP, glucosamine (GlcNH(2)), leads to increased GlcNH(2)

263 tes, wherein the rate-limiting enzyme of the HBP, glutamine:fructose-6-phosphate amidotransferase (GF

264 Here, we show that enhancement of the HBP, through the upregulation of the enzyme Phosphoacety

265 exosamines (UDP-HexNAc), end products of the HBP, were increased approximately 2- and 15-fold after a

266 To explore the molecular mechanism of the HBP-induced fatty acid oxidation in adipocytes, we studi

267 e 1 (GFAT1), the rate-limiting enzyme of the HBP.

268 oprotection in part through induction of the HBP.

269 is a direct transcriptional activator of the HBP.

270 hese results support the hypothesis that the HBP is a sensor and regulator of the actions of glucose

271 Here, we report that the HBP is activated in prostate cancer cells and that OGT i

272 Here, we show that the HBP is induced in cardiomyocytes during hypertrophic gro

273 rect measurement of glucose flux through the HBP in any organ.

274 e data to mean that glucose flux through the HBP is linked to regulation of lipogenesis through contr

275 that the excessive glucose flux through the HBP may direct retinal neurons to undergo apoptosis in a

276 d whether increased glucose flux through the HBP perturbs insulin action and induces apoptosis in ret

277 pathway, the glucose is shunted through the HBP.

278 g factor, excessive glucose flux through the HBP.

279 ies reveal that Xbp1s couples the UPR to the HBP to protect cells under stress.

280 ered that breast cancer cells upregulate the HBP, including increased O-GlcNAcation and elevated expr

281 ational surveys and to determine whether the HBP trend reversed its course with the rise in obesity.

282 merization, two structural parameters in the HBPs, for example, the molar ratio of the acceptor Couma

283 Increased flux through HBP leads to elevated post-translational addition of bet

284 Thus, HBP links the altered metabolism with aberrant glycosyla

285 The conversion of DBT to HBP is catalyzed by a multienzyme pathway consisting of

286 release of TNF-alpha or PGE2 in response to HBP and LPS.

287 We demonstrate that the UPR triggers HBP activation via Xbp1s-dependent transcription of gene

288 d forty-eight consecutive patients underwent HBP with a 3830 Select Secure lead (Medtronic, Inc) at 3

289 could be overcome by the risk of undiagnosed HBP.

290 e demonstrate a physiologic role for the UPR-HBP axis by showing that acute stimulation of Xbp1s in h

291 ablish that this previously unrecognized UPR-HBP axis is triggered in a variety of stress conditions.

292 been elucidated, and it is not known whether HBP also increases the LPS-induced production of other b

293 To date, the mechanisms by which HBP enhances LPS-induced monocyte activation have not be

294 alization is an important mechanism by which HBP enhances LPS-induced TNF-alpha release.

295 The mechanisms by which HBP reduces septic death are not fully understood, but t

296 We also highlight the challenges with HBP and the need for additional tools and more randomize

297 sess autocapture algorithms for devices with HBP.

298 rying covariate, comparing those on PCB with HBP with those on PC gave an OS hazard ratio (HR) of 0.6

299 < .0001) and comparing those on PCB without HBP to those on PC, the HR was 0.72 (95% CI, 0.62 to 0.8

300 1; P = .001); comparing those on PCB without HBP with those on PC alone, the OS HR was 0.86 (95% CI,